The Effect of Adiponectin-Leptin Ratio on Weight Loss in Patients Undergoing Sleeve Gastrectomy Due to Morbid Obesity

The study aims to find out if a specific blood test, measuring the balance between two hormones (adiponectin and leptin), can predict how much weight a person might lose after sleeve gastrectomy, a surgery for obesity. The investigators want to see if this hormone ratio can help identify who will benefit most from the surgery. If the investigators find that people with a low hormone ratio are less likely to lose weight after surgery, doctors can guide them toward other weight-loss options, like lifestyle changes or different treatments, instead of surgery. This way, patients can get the care that's best for them.

NCT Number	NCT07564973
Lead Sponsor	Sercan YUKSEL, MD
Conditions	Morbid Obesity Requiring Bariatric Surgery
Enrollment	78 participants
Start Date	2025-01-01
Primary Completion	2026-03-31 (estimated)
Study Completion	2026-04-27 (estimated)
Updated on ClinicalTrials.gov	2026-05-07